Litigation Details for HELSINN HEALTHCARE S.A. v. GLAND PHARMA LIMITED (D.N.J. 2022)
✉ Email this page to a colleague
HELSINN HEALTHCARE S.A. v. GLAND PHARMA LIMITED (D.N.J. 2022)
| Docket | ⤷ Try a Trial | Date Filed | 2022-07-18 |
| Court | District Court, D. New Jersey | Date Terminated | 2022-12-23 |
| Cause | 35:271 Patent Infringement | Assigned To | Zahid Nisar Quraishi |
| Jury Demand | None | Referred To | Lois H. Goodman |
| Parties | HELSINN HEALTHCARE S.A. | ||
| Patents | 10,208,073; 8,426,450; 8,623,826; 8,895,586; 9,186,357; 9,271,975; 9,403,772; 9,908,907; 9,943,515 | ||
| Attorneys | WILLIAM C. BATON | ||
| Firms | Midlige Richter LLC | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in HELSINN HEALTHCARE S.A. v. GLAND PHARMA LIMITED
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for HELSINN HEALTHCARE S.A. v. GLAND PHARMA LIMITED (D.N.J. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2022-07-18 | 1 | Exhibits A-J | States Patent (10) Patent No.: US 10,208,073 B2 …: 158 U.S. Patent Feb. 19, 2019 US 10,208,073 B2 … US 10,208,073 B2 … US 10,208,073 B2 1 … US 10,208,073 B2 3 eroaryl | External link to document |
| 2022-10-11 | 25 | Counterclaim AND Amended Answer to Complaint | the ’772 patent”), U.S. Patent No. 9,908,907 (“the ’907 patent”), U.S. Patent No. 10,208,073 (“the ’073…,907 (“the ’907 patent”), U.S. Patent No. 10,208,073 (“the ’073 patent”), U.S. Patent No. 10,624,911 … Patent No. 9,908,907 (“the ’907 patent”), U.S. Patent No. 10,208,073 (“the ’073 patent”), U.S. Patent…’450 patent, the ’586 patent, the ’357 patent, the ’772 patent, the ’907 patent, the ’073 patent, the …’450 patent, the ’586 patent, the ’357 patent, the ’772 patent, the ’907 patent, the ’073 patent, the | External link to document |
| 2022-10-25 | 31 | Answer to Counterclaim | ,907 (“the ’907 patent”), U.S. Patent No. 10,208,073 (“the ’073 patent”), U.S. Patent No. 10,624,911 …’450 patent, the ’586 patent, the ’357 patent, the ’772 patent, the ’907 patent, the ’073 patent, the…of U.S. Patent No. 8,426,450 (“the ’450 patent”), U.S. Patent No. 8,895,586 (“the ’586 patent”), U.S.…U.S. Patent No. 9,186,357 (“the ’357 patent”), U.S. Patent No. 9,403,772 (“the ’772 patent”), U.S. Patent…10,624,911 (“the ’911 patent”), U.S. Patent No. 10,717,721 (“the ’721 patent”), U.S. Patent No. 10,828,297 (“the | External link to document |
| 2023-01-17 | 48 | Redacted Document | infringement of U.S. Patent Nos. 8,426,450, 8,895,586, 9,186,357, 9,403,772, 9,908,907, 10,208,073, 10,624,911…infringement of U.S. Patent Nos. 8,426,450, 8,895,586, 9,186,357, 9,403,772, 9,908,907, 10,208,073, 10,624,911…expiration of the Helsinn Patents was a technical act of infringement of the Helsinn Patents under 35 U.S.C. §…expiration of the Helsinn Patents was a technical act of infringement of the Helsinn Patents under 35 U.S.C. …JUDGMENT AND DISMISSAL ORDER This action for patent infringement (the “Litigation”) has been brought | External link to document |
| 2023-01-19 | 50 | Order | infringement of U.S. Patent Nos. 8,426,450, 8,895,586, 9,186,357, 9,403,772, 9,908,907, 10,208,073, 10,624,911,…expiration of the Helsinn Patents was a technical act of infringement of the Helsinn Patents under 35 U.S.C. §…CONSENT JUDGMENT AND DISMISSAL ORDER This action for patent infringement (the “Litigation”) has been brought…,721, 10,828,297, and 11,312,698 (the “Helsinn Patents”). Helsinn’s commencement of the Litigation was… § 355G@)(2)(A)WiDCYV) directed to the Helsinn Patents and seeking approval to market generic EQ 11.75 | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
